Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Delaware guideDelaware Bids and Bidding Guide
  • Consulting Services RFPsConsulting Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More consulting services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Delaware
  4. ›Closed bids
  5. ›Advancing Health Equity for Populations with or at Risk for Diabetes

State of Delaware HSS·Delaware

Advancing Health Equity for Populations with or at Risk for Diabetes

Closes 3/30/2026$1M – $3MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The State of Delaware’s Department of Health and Social Services is seeking a professional‑services vendor to design and implement a strategic, equity‑focused diabetes prevention and management program for priority populations. The effort is organized into several “strategies” (e.g., DSMES expansion, Medicaid coverage advocacy, team‑based care, National DPP enrollment, e‑referral system) and vendors may propose to address any subset of these. The contract is a five‑year fixed‑fee award with optional one‑year extensions, milestone‑based payments, and a requirement to keep pricing fixed through July 31 2028. The vendor must provide technical assistance, data collection, monthly usage reporting, and comply with HIPAA/Part 2, DTI cloud‑service standards, and extensive insurance and background‑check requirements. • Scope includes expanding diabetes self‑management education, improving coverage for DSMES and National DPP, building e‑referral pathways, and supporting team‑based clinical care. • Deliverables: monthly progress reports, quarterly subcontractor diversity reports, data‑management via Smartsheet, and adherence to CDC/ADA outcome metrics. • Mandatory compliance: BAA, insurance minimums ($1 M/$3 M), background checks, U.S.‑only data handling, and strict reporting timelines.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Maurica Sampson(RFP Designated Contact (Contracts, Management & Procurement))

[email protected]

(302) 744-4924

Key dates

Opened
2/9/2026
Questions due
3/2/2026
Closes
3/30/2026
Projected award
5/29/2026
Duration
5 years

Last updated

Details

Type
Request for Proposal
Industry
Consulting Services
NAICS
541611
Solicitation №
HSS26050-DIABETES

Budget estimate

$1,000,000 – $3,000,000

The solicitation notes a total annual funding pool of up to $500,000, with a five‑year base term. Assuming the award could capture the full annual amount and possibly include optional extensions, the contract value could range from roughly $1 million (partial funding or limited scope) to $3 million (full five‑year funding plus extensions and additional optional services). The estimate reflects the fixed‑fee nature of the award, the mandatory insurance and compliance costs, and typical consultant rates for health‑equity programs.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 71%

Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. Center for Medicare and Medicaid Services·United States of America

71% match

Health Equity Data Access Program (HEDAP)

Rolling / TBD closeOpened 7/25/2024

U.S. Centers for Disease Control and Prevention - ERA·United States of America

70% match

Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management

Closes 4/20/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

69% match

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)

Closes 1/7/2028Opened 8/27/2024

U.S. National Institutes of Health·United States of America

67% match

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Closes 10/12/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

67% match

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Closes 1/7/2027Opened 4/19/2023

U.S. Food and Drug Administration·United States of America

67% match

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 12/8/2023

U.S. National Institutes of Health·United States of America

66% match

Diabetes Research Centers (P30 Clinical Trial Optional)

Closes 1/27/2027Opened 5/27/2025

U.S. Agency For International Development·United States of America

66% match

INNOVATIVE HEALTH PRACTICES

Closes 2/20/2028Opened 6/25/2024

U.S. National Institutes of Health·United States of America

66% match

Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes

Closes 2/10/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

66% match

Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 12/13/2021

U.S. Centers for Disease Control - NCHHSTP·United States of America

65% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. Indian Health Service·United States of America

65% match

National Urban Indian Health Program (Education and Research)

Closes 1/31/2027Opened 8/6/2026

U.S. National Institutes of Health·United States of America

65% match

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Closes 1/7/2028Opened 5/13/2024

U.S. Centers for Disease Control - NCHHSTP·United States of America

64% match

Demonstration Projects for Whole-Person Health Models for Women Living with HIV in the South

Closes 4/13/2027Opened 7/29/2026

U.S. Indian Health Service·United States of America

64% match

Domestic Violence Prevention

Closes 3/31/2027Opened 8/6/2026

Texas Workforce Commission·Texas

64% match

Open Enrollment (OE) for Diabetes Self-Management Education Services

Closes 2/26/2027Opened 5/14/2026

U.S. National Institutes of Health·United States of America

64% match

Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)

Closes 2/15/2027Opened 8/25/2026

U.S. National Institutes of Health·United States of America

64% match

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Closes 3/10/2027Opened 9/18/2025

U.S. Bureau of Global Health Security and Diplomacy·United States of America

64% match

Advancing Global Health

Closes 2/14/2027Opened 4/14/2026

U.S. CENTERS FOR DISEASE CONTROL CSTLTS·United States of America

64% match

Strengthening Public Health Systems and Services in Indian Country

Closes 5/1/2027Opened 7/31/2026

U.S. National Institutes of Health·United States of America

64% match

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Closes 5/7/2027Opened 8/16/2023

U.S. National Institutes of Health·United States of America

64% match

Immune Drivers of Autoimmune Disease

Closes 6/10/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

64% match

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Closes 3/9/2027Opened 8/4/2026